Table of Contents
A randomized, controlled neuroimaging study published in May 2026 has measured what happens inside the brain when healthy volunteers take an oral combination of DMT and harmine, the two primary pharmacological constituents of the traditional brew ayahuasca. Using fluorodeoxyglucose positron emission tomography, or FDG-PET, researchers found a 12.5 percent increase in global cerebral glucose metabolism following a single acute dose. The pattern of that increase was not uniform; it concentrated in higher-order brain networks, the regions associated with complex cognition, self-referential thought, and integration of sensory information.
What FDG-PET Imaging Showed in the Living Brain
FDG-PET is a well-established method for tracing how actively different brain regions are consuming glucose, the primary fuel of neural activity. A global rise of 12.5 percent is a substantial shift, and the fact that it was not distributed randomly across the brain matters. Higher-order networks, sometimes called association cortices, are among the most evolutionarily recent structures in the human brain. They sit at the top of sensory hierarchies, binding disparate signals into coherent experience and supporting the kind of reflective awareness that practitioners of contemplative traditions have long sought to deepen.
A Shared Metabolic Signature with Psilocybin
The study’s authors note that this cerebral glucose metabolism profile mirrors what has been observed with psilocybin in prior neuroimaging work. That parallel is scientifically significant. DMT and psilocybin act on overlapping receptor populations, particularly serotonin 2A receptors, but they arrive at the brain by different routes and at different speeds. The fact that both compounds produce a comparable pattern of increased glucose metabolism in higher-order brain networks suggests a possible common mechanism underlying their effects, one that may prove relevant to understanding why classical psychedelics are being studied for conditions ranging from depression to post-traumatic stress.
Does an Oral Ayahuasca Analog Produce the Same Brain Effects as Ayahuasca?
Based on this trial, an oral DMT and harmine combination produces a measurable increase in global cerebral glucose metabolism concentrated in higher-order brain networks, a pattern consistent with what neuroimaging research has recorded for other classical psychedelics. The combination replicates the core pharmacology of the traditional brew in a controlled, oral form, making it suitable for randomized study designs that would be difficult to conduct with the brew itself.
Scope and Caution
This was a study in healthy volunteers, not a patient population, and the primary outcome was metabolic change rather than therapeutic benefit. The randomized trial design strengthens confidence in the results, but a single study, even a well-designed one, is hypothesis-generating rather than conclusive. It raises pointed questions: Does the magnitude of metabolic increase correlate with the depth of subjective experience? Do individuals who show greater activation in higher-order networks report more enduring changes afterward? These questions remain open. What the study contributes is a cleaner neurobiological picture of what an ayahuasca-analog dose actually does to the living brain in the hours after ingestion, measured with the same imaging tools used across cardiology and oncology every day.
Why the DMT and Harmine Combination Matters for Psychedelic Research
Oral DMT and harmine together form a pharmacologically precise analog to ayahuasca, one that researchers can standardize and study under rigorous controlled conditions. Finding that this combination raises global cerebral glucose metabolism by 12.5 percent, especially in higher-order association cortices, gives scientists a reproducible neurobiological marker to work with as clinical interest in psilocybin neuroplasticity and psychedelic-assisted approaches continues to grow.
The Brain Lit From Within
There is something quietly humbling about watching the language of metabolic medicine catch up to what traditions built around ayahuasca have described for generations: that this medicine stirs something deep, something that touches the parts of us responsible for making meaning. The higher-order networks this study highlights are not peripheral. They are the seat of how we understand ourselves and relate to the world.
A 12.5 percent increase in global glucose metabolism is not an abstraction. It is the brain working harder, in regions that normally govern the stories we tell about who we are. Whether that extra metabolic work translates into lasting change depends on what happens next, on how the experience is received, held, and woven into daily life.
This is exactly where the inner path begins. The scan can show that something moved. Only the practitioner can say what it moved toward.
If this finding stirs your curiosity about the relationship between brain, mind, and sacred experience, we welcome you to sit with it in community. The station of Awakening on the Golden Path invites us to meet new understanding not with conclusions but with open questions. Share what arises for you in the comments, or bring it to one of our integration circles.
May love guide the hearts of all beings.
